D. E. Shaw & Co »

Exagen shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Exagen (XGN) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $104k 35k 3.00
2025-12-31 $192k 32k 6.08

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Exagen

Balyasny Asset Management
Wexford Capital
Rtw Investments
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Silvercrest Asset Management Group
Kennedy Capital Management
FourWorld Capital Management
Mink Brook Asset Management
Susquehanna International
Squarepoint Ops
GSA Capital Partners
Nano Cap New Millennium Growth Fund
Sei Investments

View all funds holding Exagen